Transdermal fentanyl versussustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life
Open Access
- 1 May 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 13 (5) , 254-261
- https://doi.org/10.1016/s0885-3924(97)00082-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer painPain, 1996
- Opioid rotation for toxicity reduction in terminal cancer patientsJournal of Pain and Symptom Management, 1995
- Multicentre study of cancer pain and its treatment in FranceBMJ, 1995
- Withdrawal with transdermal fentanylJournal of Pain and Symptom Management, 1995
- Recent clinical trials of pain control: Impact on quality of lifeEuropean Journal Of Cancer, 1995
- Withdrawal symptoms during therapy with transdermal fentanyl (fentanyl TTS)?Journal of Pain and Symptom Management, 1994
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. A pilot study with 20 terminally ill cancer patientsPain, 1992
- The memorial pain assessment card. A valid instrument for the evaluation of cancer painCancer, 1987